Literature DB >> 33971823

Measurement of fasting breath hydrogen concentration as a simple diagnostic method for pancreatic exocrine insufficiency.

Kota Uetsuki1, Hiroki Kawashima2, Eizaburo Ohno1, Takuya Ishikawa1, Tadashi Iida1, Kenta Yamamoto1, Kazuhiro Furukawa1, Masanao Nakamura1, Takashi Honda1, Masatoshi Ishigami1, Yoshiki Hirooka3, Mitsuhiro Fujishiro1.   

Abstract

BACKGROUND: Pancreatic exocrine insufficiency (PEI) is associated with the outcome of pancreatic disease. However, there is no method for assessing PEI that can be used noninvasively and easily for outpatient. It has been reported that changes in intestinal bacteria caused by PEI may increase breath hydrogen concentration (BHC) levels during glucose or lactose loading. We have evaluated the usefulness of fasting breath hydrogen concentration (FBHC) measurement without glucose loading for the evaluation of PEI.
METHODS: Sixty patients underwent FBHC measurement, BT-PABA testing, and microbiome analysis. They were classified into PEI group (PABA excretion rate < 73.4%, n = 30) and non-PEI group (n = 30). The FBHC of the two groups were compared, and the diagnostic ability of PEI by them was evaluated. The 16 s rRNA (V3-V4) from fecal samples was analyzed by MiSeq.
RESULTS: FBHC levels was higher in the PEI group 15.70 (1.4 to 77.0) ppm than in the non-PEI group 2.80 (0.7 to 28.2) ppm (P < 0.0001). FBHC was negatively correlated with PABA excretion rate (r =  - 0.523, P < 0.001). The cutoff value of FBHC of 10.7 ppm (95% CI: 0.678-0.913, P < 0.001) showed a sensitivity of 73.3% and specificity of 83.3% for PEI diagnosis. In the PEI group, there was a significant increase of relative abundance of phylum Firmicutes (P < 0.05) and the genus Clostridium (P < 0.05).
CONCLUSION: FBHC shows good potential as a simple and repeatable test for the diagnosis of PEI. The elevated FBHC levels may be caused by hydrogen-producing bacteria such as Clostridium.

Entities:  

Keywords:  Fasting breath hydrogen concentration; Non-invasive measurement; Pancreatic disease; Pancreatic exocrine insufficiency

Year:  2021        PMID: 33971823     DOI: 10.1186/s12876-021-01776-8

Source DB:  PubMed          Journal:  BMC Gastroenterol        ISSN: 1471-230X            Impact factor:   3.067


  32 in total

1.  Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference.

Authors:  A Gasbarrini; G R Corazza; G Gasbarrini; M Montalto; M Di Stefano; G Basilisco; A Parodi; P Usai-Satta; P U Satta; P Vernia; C Anania; M Astegiano; G Barbara; L Benini; P Bonazzi; G Capurso; M Certo; A Colecchia; L Cuoco; A Di Sario; D Festi; C Lauritano; E Miceli; G Nardone; F Perri; P Portincasa; R Risicato; M Sorge; A Tursi
Journal:  Aliment Pharmacol Ther       Date:  2009-03-30       Impact factor: 8.171

2.  The prevalence of small intestinal bacterial overgrowth in non-surgical patients with chronic pancreatitis and pancreatic exocrine insufficiency (PEI).

Authors:  Hazel M Ní Chonchubhair; Yasir Bashir; Mark Dobson; Barbara M Ryan; Sinead N Duggan; Kevin C Conlon
Journal:  Pancreatology       Date:  2018-02-24       Impact factor: 3.996

3.  Increase in breath hydrogen concentration was correlated with the main pancreatic duct stenosis.

Authors:  Daisuke Sakai; Yoshiki Hirooka; Hiroki Kawashima; Eizaburo Ohno; Takuya Ishikawa; Hiroki Suhara; Tomoaki Takeyama; Toshinari Koya; Hiroyuki Tanaka; Tadashi Iida; Ryo Nishio; Hirotaka Suzuki; Kota Uetsuki; Masanobu Matsushita; Takeshi Yamamura; Kazuhiro Furukawa; Kohei Funasaka; Masanao Nakamura; Ryoji Miyahara; Osamu Watanabe; Masatoshi Ishigami; Akihiro Tsuruta; Woosuck Shin; Hidemi Goto
Journal:  J Breath Res       Date:  2018-03-12       Impact factor: 3.262

Review 4.  Diagnosis and treatment of pancreatic exocrine insufficiency.

Authors:  Björn Lindkvist
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

5.  Hydrogen breath test--diet and basal H2 excretion: a technical note.

Authors:  E V Avallone; A De Carolis; P Loizos; C Corrado; P Vernia
Journal:  Digestion       Date:  2010-02-27       Impact factor: 3.216

6.  Small Intestinal Bacterial Overgrowth Is Common in Chronic Pancreatitis and Associates With Diabetes, Chronic Pancreatitis Severity, Low Zinc Levels, and Opiate Use.

Authors:  Allen A Lee; Jason R Baker; Erik J Wamsteker; Richard Saad; Matthew J DiMagno
Journal:  Am J Gastroenterol       Date:  2019-07       Impact factor: 10.864

Review 7.  The assessment of pancreatic exocrine function in patients with inoperable pancreatic cancer: In need of a new gold-standard.

Authors:  Lindsay E Carnie; Angela Lamarca; Mairéad G McNamara; Neil Bibby; Derek A O'Reilly; Juan W Valle
Journal:  Pancreatology       Date:  2020-04-02       Impact factor: 3.996

Review 8.  Pancreatic exocrine insufficiency in pancreatic cancer: A review of the literature.

Authors:  Michael J Bartel; Horatio Asbun; John Stauffer; Massimo Raimondo
Journal:  Dig Liver Dis       Date:  2015-07-06       Impact factor: 4.088

Review 9.  Exocrine pancreatic insufficiency: prevalence, diagnosis, and management.

Authors:  Gabriele Capurso; Mariaemilia Traini; Matteo Piciucchi; Marianna Signoretti; Paolo Giorgio Arcidiacono
Journal:  Clin Exp Gastroenterol       Date:  2019-03-21

Review 10.  Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis.

Authors:  Daniel de la Iglesia-García; Wei Huang; Peter Szatmary; Iria Baston-Rey; Jaime Gonzalez-Lopez; Guillermo Prada-Ramallal; Rajarshi Mukherjee; Quentin M Nunes; J Enrique Domínguez-Muñoz; Robert Sutton
Journal:  Gut       Date:  2016-12-09       Impact factor: 23.059

View more
  1 in total

1.  Modification of baseline status to improve breath tests performance.

Authors:  Estibaliz Alegre; Amaia Sandúa; Sofía Calleja; Sara Deza; Álvaro González
Journal:  Sci Rep       Date:  2022-06-13       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.